❌

Normal view

Membranolytic peptide programs immunogenic cell death for cancer therapy

Nature, Published online: 05 August 2026; doi:10.1038/s41586-026-10899-5

The synthetic-acid-responsive membranolytic peptide aMPC16-CA50 induces immunogenic membranolytic cell death in tumour cells, robustly potentiating immune checkpoint blockade therapy.

Author Correction: PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components

9 June 2026 at 01:00

Nature, Published online: 09 June 2026; doi:10.1038/s41586-026-10769-0

Author Correction: PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components
❌